| extracellular matrix organization | GO:0030198 | 147 | 0.997 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.995 | |
| bone development | GO:0060348 | 120 | 0.993 | |
| extracellular structure organization | GO:0043062 | 148 | 0.991 | |
| collagen fibril organization | GO:0030199 | 32 | 0.989 | |
| skeletal system development | GO:0001501 | 356 | 0.989 | Human Mouse |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.985 | |
| cartilage condensation | GO:0001502 | 18 | 0.984 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.984 | |
| growth plate cartilage development | GO:0003417 | 14 | 0.983 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.982 | |
| connective tissue development | GO:0061448 | 179 | 0.980 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.975 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.974 | Mouse |
| negative regulation of cell motility | GO:2000146 | 61 | 0.964 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.963 | Mouse |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.953 | |
| face morphogenesis | GO:0060325 | 29 | 0.950 | |
| cell aggregation | GO:0098743 | 18 | 0.944 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.944 | |
| limb development | GO:0060173 | 166 | 0.943 | Mouse |
| blood circulation | GO:0008015 | 195 | 0.940 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.939 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.935 | |
| bone morphogenesis | GO:0060349 | 78 | 0.933 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.933 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.923 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.920 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.915 | |
| chondrocyte development | GO:0002063 | 24 | 0.907 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.901 | |
| head morphogenesis | GO:0060323 | 34 | 0.892 | |
| response to oxidative stress | GO:0006979 | 123 | 0.886 | |
| respiratory system development | GO:0060541 | 190 | 0.882 | |
| extracellular matrix assembly | GO:0085029 | 12 | 0.882 | |
| positive regulation of axon extension | GO:0045773 | 20 | 0.871 | |
| cartilage development | GO:0051216 | 140 | 0.871 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.837 | |
| negative regulation of blood circulation | GO:1903523 | 15 | 0.837 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.833 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.828 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.828 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.826 | |
| positive regulation of interferon gamma secretion | GO:1902715 | 3 | 0.822 | |
| cellular response to fluid shear stress | GO:0071498 | 4 | 0.816 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.815 | |
| respiratory tube development | GO:0030323 | 167 | 0.801 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.798 | |
| lung alveolus development | GO:0048286 | 45 | 0.796 | |
| aorta smooth muscle tissue morphogenesis | GO:0060414 | 2 | 0.786 | |
| skin development | GO:0043588 | 220 | 0.776 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.770 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.767 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.763 | |
| lung development | GO:0030324 | 164 | 0.756 | |
| response to oxygen levels | GO:0070482 | 62 | 0.752 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.752 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.752 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.749 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.741 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.731 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.730 | |
| response to growth factor | GO:0070848 | 198 | 0.723 | |
| muscle tissue development | GO:0060537 | 308 | 0.722 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.720 | |
| protein catabolic process | GO:0030163 | 221 | 0.719 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.708 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.704 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.704 | |
| oxidation reduction process | GO:0055114 | 342 | 0.693 | |
| endochondral bone growth | GO:0003416 | 19 | 0.693 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.691 | |
| female gonad development | GO:0008585 | 71 | 0.680 | |
| replacement ossification | GO:0036075 | 26 | 0.677 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.676 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.672 | |
| response to superoxide | GO:0000303 | 16 | 0.669 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.664 | |
| amine metabolic process | GO:0009308 | 45 | 0.653 | |
| protein heterotrimerization | GO:0070208 | 8 | 0.644 | |
| renal system development | GO:0072001 | 225 | 0.644 | |
| ovarian follicle development | GO:0001541 | 40 | 0.635 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.624 | |
| response to hypoxia | GO:0001666 | 58 | 0.619 | |
| regulation of cell migration | GO:0030334 | 219 | 0.619 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.606 | |
| response to steroid hormone | GO:0048545 | 56 | 0.602 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.602 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.600 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.580 | |
| positive regulation of metanephros development | GO:0072216 | 9 | 0.577 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.574 | |
| bone mineralization | GO:0030282 | 54 | 0.571 | Mouse |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.567 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.556 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.545 | |
| limb morphogenesis | GO:0035108 | 149 | 0.544 | Mouse |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.540 | |
| regulation of monooxygenase activity | GO:0032768 | 7 | 0.540 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.535 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.534 | |
| response to amino acid | GO:0043200 | 37 | 0.531 | |
| lymph vessel morphogenesis | GO:0036303 | 11 | 0.525 | |
| circulatory system process | GO:0003013 | 197 | 0.524 | |
| molting cycle | GO:0042303 | 90 | 0.519 | Worm |
| response to oxygen radical | GO:0000305 | 16 | 0.516 | |
| regulation of cell aging | GO:0090342 | 9 | 0.511 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.509 | |
| negative regulation of cartilage development | GO:0061037 | 17 | 0.504 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.495 | |
| inflammatory response | GO:0006954 | 244 | 0.484 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.481 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.471 | |
| appendage development | GO:0048736 | 166 | 0.470 | Mouse |
| multicellular organismal catabolic process | GO:0044243 | 7 | 0.468 | |
| bronchus morphogenesis | GO:0060434 | 2 | 0.468 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.465 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.461 | |
| response to activity | GO:0014823 | 13 | 0.458 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.458 | |
| bone resorption | GO:0045453 | 38 | 0.452 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.445 | |
| response to light stimulus | GO:0009416 | 135 | 0.438 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.435 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.435 | |
| regulation of protein transport | GO:0051223 | 163 | 0.435 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.433 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.433 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.433 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.430 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.429 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.429 | |
| regulation of cell motility | GO:2000145 | 236 | 0.426 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.420 | |
| response to hyperoxia | GO:0055093 | 2 | 0.417 | |
| forebrain development | GO:0030900 | 302 | 0.410 | |
| regulation of system process | GO:0044057 | 200 | 0.410 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.408 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.406 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.404 | |
| striated muscle cell development | GO:0055002 | 125 | 0.402 | |
| face development | GO:0060324 | 38 | 0.400 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.398 | |
| stem cell development | GO:0048864 | 219 | 0.397 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.395 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.394 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.392 | |
| digestive tract development | GO:0048565 | 190 | 0.388 | |
| response to inorganic substance | GO:0010035 | 96 | 0.383 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.382 | |
| cell chemotaxis | GO:0060326 | 81 | 0.375 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.369 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.367 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.360 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.357 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.357 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.345 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.344 | |
| regulation of lung blood pressure | GO:0014916 | 2 | 0.339 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.338 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.338 | |
| regulation of anti mullerian hormone signaling pathway | GO:1902612 | 1 | 0.337 | |
| response to radiation | GO:0009314 | 165 | 0.337 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.333 | |
| superoxide anion generation | GO:0042554 | 11 | 0.333 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.332 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.326 | |
| regulation of protein localization | GO:0032880 | 231 | 0.324 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.322 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.321 | |
| regulation of membrane protein ectodomain proteolysis | GO:0051043 | 3 | 0.320 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.319 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.314 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.308 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.307 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.305 | |
| body morphogenesis | GO:0010171 | 45 | 0.302 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.301 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.301 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.300 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.296 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.295 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.294 | |
| hair follicle development | GO:0001942 | 85 | 0.290 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.289 | |
| digestive system development | GO:0055123 | 200 | 0.289 | |
| endothelial cell proliferation | GO:0001935 | 27 | 0.289 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.288 | |
| axonogenesis | GO:0007409 | 274 | 0.284 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.283 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.280 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.279 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.275 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.274 | |
| nephron development | GO:0072006 | 109 | 0.274 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.270 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.269 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.267 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.264 | |
| female sex differentiation | GO:0046660 | 84 | 0.264 | |
| tissue homeostasis | GO:0001894 | 115 | 0.263 | |
| regulation of tube size | GO:0035150 | 57 | 0.259 | |
| regulation of tolerance induction to self antigen | GO:0002649 | 1 | 0.256 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.255 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.251 | |
| stem cell differentiation | GO:0048863 | 268 | 0.251 | |
| positive regulation of dendritic spine development | GO:0060999 | 12 | 0.249 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.248 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.248 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.246 | |
| regulation of response to osmotic stress | GO:0047484 | 3 | 0.244 | |
| rhythmic process | GO:0048511 | 174 | 0.243 | |
| heart process | GO:0003015 | 94 | 0.243 | |
| direct ossification | GO:0036072 | 5 | 0.241 | |
| urogenital system development | GO:0001655 | 261 | 0.239 | |
| regulation of secretion | GO:0051046 | 274 | 0.239 | |
| axon guidance | GO:0007411 | 141 | 0.237 | |
| endoderm formation | GO:0001706 | 20 | 0.237 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.236 | |
| dopamine metabolic process | GO:0042417 | 23 | 0.236 | |
| angiogenesis | GO:0001525 | 201 | 0.236 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.235 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.235 | |
| endoderm development | GO:0007492 | 45 | 0.235 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.232 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.231 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.229 | |
| antibacterial peptide biosynthetic process | GO:0002780 | 2 | 0.222 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.222 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.222 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.220 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.218 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.218 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.215 | Mouse |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.214 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.213 | |
| negative regulation of vasoconstriction | GO:0045906 | 2 | 0.210 | |
| vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | GO:0002033 | 2 | 0.210 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.209 | |
| response to monosaccharide | GO:0034284 | 67 | 0.208 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.207 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.206 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.206 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.205 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.201 | |
| growth plate cartilage chondrocyte development | GO:0003431 | 3 | 0.201 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.200 | |
| dendrite development | GO:0016358 | 115 | 0.198 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 13 | 0.198 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.197 | |
| ovulation cycle | GO:0042698 | 59 | 0.197 | |
| male gamete generation | GO:0048232 | 285 | 0.196 | |
| indolalkylamine metabolic process | GO:0006586 | 4 | 0.195 | |
| transmembrane transport | GO:0055085 | 412 | 0.195 | |
| negative regulation of macrophage chemotaxis | GO:0010760 | 1 | 0.195 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.192 | |
| negative regulation of cardiac muscle tissue development | GO:0055026 | 8 | 0.192 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.192 | |
| muscle contraction | GO:0006936 | 101 | 0.190 | |
| renal system process | GO:0003014 | 48 | 0.189 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.186 | |
| basement membrane organization | GO:0071711 | 8 | 0.184 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.184 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.183 | |
| artery development | GO:0060840 | 53 | 0.182 | |
| cholesterol import | GO:0070508 | 2 | 0.182 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.182 | |
| peptide metabolic process | GO:0006518 | 46 | 0.181 | |
| peptide transport | GO:0015833 | 133 | 0.178 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.177 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.176 | |
| insulin secretion | GO:0030073 | 89 | 0.176 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.174 | |
| tissue remodeling | GO:0048771 | 102 | 0.174 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.174 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.173 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.172 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.172 | |
| response to osmotic stress | GO:0006970 | 21 | 0.171 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.171 | |
| negative regulation of heart rate | GO:0010459 | 4 | 0.170 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.170 | |
| fused antrum stage | GO:0048165 | 1 | 0.170 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.169 | |
| response to acid chemical | GO:0001101 | 111 | 0.168 | |
| regulation of response to reactive oxygen species | GO:1901031 | 9 | 0.166 | |
| gastrulation | GO:0007369 | 116 | 0.165 | |
| bone trabecula formation | GO:0060346 | 9 | 0.163 | Mouse |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.160 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.160 | |
| cell adhesion | GO:0007155 | 329 | 0.160 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.159 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.159 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.156 | |
| regulation of neurotrophin trk receptor signaling pathway | GO:0051386 | 4 | 0.156 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.154 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.154 | |
| vasodilation | GO:0042311 | 28 | 0.154 | |
| synaptic transmission | GO:0007268 | 329 | 0.154 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.154 | |
| regulation of protein binding | GO:0043393 | 60 | 0.153 | |
| positive regulation of tolerance induction to self antigen | GO:0002651 | 1 | 0.153 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.152 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.151 | |
| antimicrobial peptide secretion | GO:0002776 | 1 | 0.151 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.151 | |
| positive regulation of response to oxidative stress | GO:1902884 | 6 | 0.151 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.150 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.150 | |
| neuron death | GO:0070997 | 154 | 0.150 | |
| antibacterial humoral response | GO:0019731 | 8 | 0.149 | |
| regulation of axon extension | GO:0030516 | 43 | 0.148 | |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.147 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.146 | |
| hormone secretion | GO:0046879 | 128 | 0.146 | |
| regeneration | GO:0031099 | 38 | 0.145 | |
| protein processing | GO:0016485 | 163 | 0.145 | |
| peptide secretion | GO:0002790 | 114 | 0.144 | |
| cellular response to lipid | GO:0071396 | 145 | 0.141 | |
| response to fluid shear stress | GO:0034405 | 7 | 0.141 | |
| nitric oxide mediated signal transduction | GO:0007263 | 4 | 0.139 | |
| regionalization | GO:0003002 | 337 | 0.139 | |
| neural plate mediolateral regionalization | GO:0021998 | 1 | 0.138 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.138 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.138 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.137 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.136 | |
| metanephric glomerulus development | GO:0072224 | 13 | 0.136 | |
| positive regulation of monooxygenase activity | GO:0032770 | 2 | 0.135 | |
| response to estrogen | GO:0043627 | 24 | 0.135 | |
| collagen metabolic process | GO:0032963 | 17 | 0.135 | |
| kidney epithelium development | GO:0072073 | 121 | 0.133 | |
| tendon development | GO:0035989 | 6 | 0.130 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.130 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.129 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.129 | |
| cellular response to sterol depletion | GO:0071501 | 4 | 0.126 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.126 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.124 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.122 | |
| vasoconstriction | GO:0042310 | 27 | 0.121 | |
| negative regulation of neuron migration | GO:2001223 | 6 | 0.121 | |
| regulation of endodermal cell differentiation | GO:1903224 | 2 | 0.121 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.120 | |
| hair cycle | GO:0042633 | 90 | 0.120 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 7 | 0.120 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.119 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.118 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.118 | |
| kidney development | GO:0001822 | 213 | 0.118 | |
| collagen catabolic process | GO:0030574 | 6 | 0.118 | |
| spinal cord development | GO:0021510 | 81 | 0.118 | |
| ear morphogenesis | GO:0042471 | 118 | 0.117 | |
| negative regulation of endodermal cell differentiation | GO:1903225 | 1 | 0.116 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.115 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.115 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.114 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.114 | |
| response to dexamethasone | GO:0071548 | 8 | 0.113 | |
| actin filament polymerization | GO:0030041 | 44 | 0.113 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.112 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.112 | |
| oocyte axis specification | GO:0007309 | 2 | 0.112 | |
| response to glucocorticoid | GO:0051384 | 20 | 0.112 | |
| positive regulation of filopodium assembly | GO:0051491 | 10 | 0.111 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.111 | |
| cellular response to bmp stimulus | GO:0071773 | 14 | 0.111 | |
| organ growth | GO:0035265 | 117 | 0.110 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.110 | |
| fat cell differentiation | GO:0045444 | 160 | 0.110 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.109 | |
| epithelial cell migration | GO:0010631 | 63 | 0.108 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.108 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.107 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.107 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.105 | |
| lateral mesoderm morphogenesis | GO:0048369 | 3 | 0.105 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.105 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 13 | 0.105 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.104 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.104 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.103 | |
| protein hydroxylation | GO:0018126 | 4 | 0.103 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.103 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.103 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.103 | |
| detection of chemical stimulus involved in sensory perception of taste | GO:0050912 | 3 | 0.102 | |
| negative regulation of chondrocyte differentiation | GO:0032331 | 13 | 0.101 | |
| protein polymerization | GO:0051258 | 57 | 0.100 | |
| negative regulation of anti mullerian hormone signaling pathway | GO:1902613 | 1 | 0.099 | |
| g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger | GO:0007199 | 1 | 0.098 | |
| response to nutrient levels | GO:0031667 | 109 | 0.098 | |
| renin secretion into blood stream | GO:0002001 | 5 | 0.097 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.096 | |
| aorta development | GO:0035904 | 23 | 0.095 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.095 | |
| negative regulation of heart growth | GO:0061117 | 7 | 0.095 | |
| developmental maturation | GO:0021700 | 193 | 0.095 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.094 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.094 | |
| protein trimerization | GO:0070206 | 13 | 0.094 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.093 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.093 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.091 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.091 | |
| cellular response to dexamethasone stimulus | GO:0071549 | 8 | 0.091 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.091 | |
| astrocyte cell migration | GO:0043615 | 3 | 0.090 | |
| endothelial cell migration | GO:0043542 | 44 | 0.090 | |
| nuclear import | GO:0051170 | 95 | 0.089 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.089 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.089 | |
| cellular response to corticosteroid stimulus | GO:0071384 | 13 | 0.087 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.087 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.087 | |
| biomineral tissue development | GO:0031214 | 64 | 0.087 | Mouse |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.087 | |
| response to corticosteroid | GO:0031960 | 20 | 0.086 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.086 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.085 | |
| negative regulation of signal transduction in absence of ligand | GO:1901099 | 16 | 0.085 | |
| nuclear membrane organization | GO:0071763 | 4 | 0.085 | |
| regulation of macrophage chemotaxis | GO:0010758 | 8 | 0.085 | |
| mesenchyme development | GO:0060485 | 152 | 0.085 | |
| telencephalon development | GO:0021537 | 186 | 0.085 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.085 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.084 | |
| catecholamine biosynthetic process | GO:0042423 | 11 | 0.083 | |
| locomotory behavior | GO:0007626 | 195 | 0.082 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.082 | |
| mesoderm structural organization | GO:0048338 | 1 | 0.081 | |
| membrane protein proteolysis | GO:0033619 | 10 | 0.080 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.080 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.079 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.079 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.078 | |
| nuclear transport | GO:0051169 | 139 | 0.077 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.077 | |
| regulation of interferon gamma secretion | GO:1902713 | 3 | 0.077 | |
| regulation of ossification | GO:0030278 | 112 | 0.077 | Mouse |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.077 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.076 | |
| organelle assembly | GO:0070925 | 177 | 0.076 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.076 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.076 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.076 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.076 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.075 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.075 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.074 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.073 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.073 | |
| steroid metabolic process | GO:0008202 | 119 | 0.073 | |
| response to sterol | GO:0036314 | 4 | 0.072 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.071 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.071 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.071 | |
| response to retinoic acid | GO:0032526 | 56 | 0.071 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.070 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.070 | |
| mullerian duct regression | GO:0001880 | 1 | 0.070 | |
| fibril organization | GO:0097435 | 2 | 0.069 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.069 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.069 | |
| neuron migration | GO:0001764 | 122 | 0.068 | |
| oocyte construction | GO:0007308 | 2 | 0.068 | |
| myeloid dendritic cell differentiation | GO:0043011 | 16 | 0.068 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.068 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.068 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.068 | Mouse |
| positive regulation of skeletal muscle tissue regeneration | GO:0043415 | 4 | 0.068 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.067 | |
| response to drug | GO:0042493 | 75 | 0.066 | |
